Prevalence of Hemorrhagic Myocardial Infarction in the United States

Completed

• Conditions: Acute Myocardial Infarction

• Registration Number: NCT06162039
• Lead Sponsor: Indiana University

Brief Summary

Registry analysis for prevalence of hemorrhagic myocardial infarction in the United States

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2023-11-30
• Study First Submitted QC: 2023-11-30
• Study First Posted: 2023-12-08
• Study Start: 2023-12-13
• Primary Completion: 2025-03-15
• Study Completion: 2025-03-15
• Status Verified: 2025-04
• Last Update Submitted: 2025-04-04
• Last Update Posted: 2025-04-08

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 24181

Inclusion Criteria

• Acute Myocardial Infarction - STEMI Primary PCI Availability of lab parameters and/or CMR

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Statewise proportion of Hemorrhagic Myocardial Infarction in the United States	10 years	Prevalence of Hemorrhagic Myocardial Infarction

Secondary Outcome Measures

Name	Time	Method
Statewise proportion of Acute Heart Failure in Hemorrhagic Myocardial Infarction	30 days	Prevalence of Acute Heart Failure in Hemorrhagic Myocardial Infarction
Statewise proportion of re-hospitalization in Hemorrhagic Myocardial Infarction	30 days	Prevalence of re-hospitalization in Hemorrhagic Myocardial Infarction
Statewise proportion of arrhythmia in Hemorrhagic Myocardial Infarction	30 days	Prevalence of arrhythmia in Hemorrhagic Myocardial Infarction

Trial Locations

Locations (1)

Krannert Cardiovascular Research Center; 🇺🇸 Indianapolis, Indiana, United States